Our Sponsors
7th World Congress on Controversies in Breast Cancer (CoBrCa)
Website https://go.evvnt.com/1503837-2?pid=4800 |
Edit Freely
Category breastcancer; oncology; locoregionaltherapy; imagn\ing; screening; neoadjuvant; genetics; her2; immunotherapy
Deadline: September 06, 2023 | Date: September 07, 2023-September 09, 2023
Venue/Country: Conrad Dubai, Sheikh Zayed Road, Dubai, United Arab Emirates
Updated: 2023-01-15 22:37:39 (GMT+9)
Call For Papers - CFP
Following the success of the Australasian International Breast Congress (AIBC 2022) which took place in Brisbane, Australia, from October 13-15, 2022, the 7th World Congress on Controversies in Breast Cancer (CoBrCa) will take place in Dubai, UAE, from September 7-9, 2023. CoBrCa, again, promises to be as exciting and informative as ever.CoBrCa 2023 will directly address controversial topics in breast cancer management with key issues explored and audience participation encouraged. This multi-faceted congress of interest to all involved in the treatment of breast disease will bring many top local and international experts to the UAE. Through debates, discussions and presentations, the congress will focus on issues faced by clinicians in daily practice.We look forward to your participation in this unique scientific event.Congress Co-Chairpersons:Javier Cortes, Spain Shaheenah Dawood, UAE Richard De Boer, Australia Bruce Mann, Australia Alastair Thompson, USAURLs:Tickets: https://go.evvnt.com/1503837-0?pid=4800
Website: https://go.evvnt.com/1503837-2?pid=4800Price:Physicians and Scientists - full fee: USD 790.00Category: Conferences | EducationDate and Time: 7th September 2023 at 9:00 am to 9th September 2023 at 5:00 pmVenue details: Conrad Dubai, Sheikh Zayed Road, Dubai, United Arab EmiratesKeywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.